Paris, France – January 2024 – Plantibodies has been selected to join the VCLS Neighborhood Incubation Program, a flagship initiative led by Voisin Consulting Life Sciences (VCLS). The program supports a small cohort of promising biotech startups each year, providing tailored guidance on regulatory, clinical, and CMC strategy to accelerate the path toward the clinic.
Joining the Neighborhood connects Plantibodies with a network of experts, mentors, and industry partners, and gives access to hands-on workshops and resources designed to strengthen regulatory readiness and prepare for global development.
“Being selected for the VCLS Neighborhood is a strong recognition of our platform’s potential,” said Pierre Bauër, CEO and co-founder of Plantibodies. “The program will help us translate our scientific advances into robust development plans and strengthen our ability to meet future clinical and regulatory milestones.”
The VCLS Neighborhood has become a reference incubator for healthtech startups looking to scale from preclinical stage to early clinical trials.